Global Genome Editing Market Size & Outlook, 2023-2030
Global genome editing market, 2018-2030 (US$M)
Related Markets
Global genome editing market highlights
- The global genome editing market generated a revenue of USD 7,959.6 million in 2023 and is expected to reach USD 24,995.0 million by 2030.
- The market is expected to grow at a CAGR (2024 - 2030) of 17.8% by 2030.
- In terms of segment, (crispr)/cas9 accounted for a revenue of USD 3,463.9 million in 2023.
- (CRISPR)/Cas9 is the most lucrative technology segment registering the fastest growth during the forecast period.
- In terms of region, North America was the largest revenue generating market in 2023.
- Country-wise, Kuwait is expected to register the highest CAGR from 2024 to 2030.
Global data book summary
| Market revenue in 2023 | USD 7,959.6 million |
| Market revenue in 2030 | USD 24,995.0 million |
| Growth rate | 17.8% (CAGR from 2023 to 2030) |
| Largest segment | (crispr)/cas9 |
| Fastest growing segment | (CRISPR)/Cas9 |
| Historical data covered | 2018 - 2022 |
| Base year for estimation | 2023 |
| Forecast period covered | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | (CRISPR)/Cas9, TALENs/MegaTALs, ZFN, Meganuclease |
Other key industry trends
- In terms of revenue, the North America accounted for 47.8% of the global genome editing market in 2023.
- By country, the U.S. is projected to lead the global market in terms of revenue in 2030.
- By country, Kuwait is the fastest growing regional market and is projected to reach USD 74.6 million by 2030.
(crispr)/cas9 was the largest segment with a revenue share of 43.52% in 2023. Horizon Databook has segmented the Global genome editing market based on (crispr)/cas9, talens/megatals, zfn, meganuclease covering the revenue growth of each sub-segment from 2018 to 2030.
Recently developed gene editing tools hold enormous potential in human healthcare management. Specifically, emergence of targeted genome modification that deploys designer nucleases, such as CRISPR and TALEN, have reshaped the investigation of gene function and further development of therapeutics. A broader understanding of genes is achieved using genetically engineered preclinical models.
Success of these tools in development of preclinical models which mimics human physiology and disease genotype & phenotype is expected to enhance the adoption of these technologies in the future market. Usage of these preclinical models is expected to grow in the coming years as they hold considerable potential to ensure higher success of preclinical research.
Biological models developed using gene editing tools are successfully employed to study and treat genetic and rare disease including monogenic recessive disorders that affect hematopoietic systems such as Wiskott -Aldrich syndrome and SCID. Hence, with growth of these preclinical models, this market is expected to witness lucrative growth in revenue generation.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Genome Editing Market Scope
Genome Editing Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Global genome editing market size, by regions, 2018-2030 (US$M)
Top 10 countries: Genome editing market size, 2023 (US$M)
Global genome editing market share, by technology, 2023 & 2030 (%, US$M)
Genome editing market: Opportunity assessment by country
Global genome editing market, by region, 2023 (US$M)
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
